Template:Lipoprotein disorders: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 114: Line 114:
[[Hyperlipidemia secondary prevention|Secondary Prevention]]
[[Hyperlipidemia secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
!
[[Hyperlipidemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Hyperlipidemia future or investigational therpaies|Future or Investigational Therapies]]
|-
!
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!

Revision as of 02:39, 21 September 2012